Ye Gong

2.3k total citations · 1 hit paper
90 papers, 1.5k citations indexed

About

Ye Gong is a scholar working on Epidemiology, Neurology and Molecular Biology. According to data from OpenAlex, Ye Gong has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 28 papers in Neurology and 23 papers in Molecular Biology. Recurrent topics in Ye Gong's work include Meningioma and schwannoma management (37 papers), Neurofibromatosis and Schwannoma Cases (21 papers) and Head and Neck Surgical Oncology (11 papers). Ye Gong is often cited by papers focused on Meningioma and schwannoma management (37 papers), Neurofibromatosis and Schwannoma Cases (21 papers) and Head and Neck Surgical Oncology (11 papers). Ye Gong collaborates with scholars based in China, United States and Germany. Ye Gong's co-authors include Qing Xie, Lingyang Hua, Hailiang Tang, Hongda Zhu, Daijun Wang, Ying Mao, Xiancheng Chen, Mi Tian, Hiroaki Wakimoto and Liangfu Zhou and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ye Gong

83 papers receiving 1.4k citations

Hit Papers

Biomaterials mediated 3R (remove-remodel-repair) strategy... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Gong China 23 601 475 362 222 218 90 1.5k
Ping Shi China 18 168 0.3× 434 0.9× 257 0.7× 223 1.0× 128 0.6× 77 1.2k
Hans Duimel Netherlands 19 422 0.7× 566 1.2× 294 0.8× 41 0.2× 101 0.5× 30 2.0k
Mohammed Al Balwi Saudi Arabia 21 235 0.4× 634 1.3× 162 0.4× 67 0.3× 134 0.6× 83 1.7k
Kaushik Das United States 28 314 0.5× 694 1.5× 131 0.4× 121 0.5× 292 1.3× 93 2.2k
Sheng Zhang China 25 432 0.7× 785 1.7× 198 0.5× 97 0.4× 232 1.1× 116 1.6k
H. H. Steiner Germany 17 575 1.0× 470 1.0× 661 1.8× 100 0.5× 94 0.4× 27 1.8k
Satoshi Nakamizo Japan 24 122 0.2× 423 0.9× 209 0.6× 255 1.1× 189 0.9× 62 1.9k
Rui-Li Wei China 25 182 0.3× 359 0.8× 210 0.6× 46 0.2× 98 0.4× 130 2.2k
Cindy Strehl Germany 19 162 0.3× 346 0.7× 58 0.2× 153 0.7× 168 0.8× 36 1.3k
Alessandra Pasut United States 15 192 0.3× 1.7k 3.5× 351 1.0× 229 1.0× 516 2.4× 20 2.6k

Countries citing papers authored by Ye Gong

Since Specialization
Citations

This map shows the geographic impact of Ye Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Gong more than expected).

Fields of papers citing papers by Ye Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Gong. The network helps show where Ye Gong may publish in the future.

Co-authorship network of co-authors of Ye Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Gong. A scholar is included among the top collaborators of Ye Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Gong. Ye Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yaling, Huanhuan Song, Cheng Guo, et al.. (2024). Isoliquiritigenin alleviates experimental autoimmune encephalomyelitis by modulating inflammatory and neuroprotective reactive astrocytes. Biomedicine & Pharmacotherapy. 178. 117188–117188. 4 indexed citations
2.
Li, Mengfan, et al.. (2024). Nanobiomaterials Based Sonodynamic Therapy for Treament of Helicobacter pylori Infections: A Review. Nano Biomedicine and Engineering. 16(4). 525–541. 2 indexed citations
3.
Sung, Wonmo, In Ah Kim, Jaeho Cho, et al.. (2024). Prognostic models for progression-free survival in atypical meningioma: Comparison of machine learning-based approach and the COX model in an Asian multicenter study. Radiotherapy and Oncology. 203. 110695–110695. 1 indexed citations
4.
Li, Haojin, Chen Sun, Shuo Wang, et al.. (2024). 5G Sub-band Full Duplex: 3GPP Standardization Progress and Performance Analysis. 1940–1945.
5.
Wang, Yang, Qimin Liu, Qingfang Sun, et al.. (2024). Exosomes from porcine serum as endogenous additive maintain function of boar sperm during liquid preservation at 17 °C in vitro. Theriogenology. 219. 147–156. 3 indexed citations
6.
Zhong, Ming, Tingting Pan, Ruilan Wang, et al.. (2023). Improving enteral nutrition tolerance and protein intake maybe beneficial to intensive care unit patients. Scientific Reports. 13(1). 21614–21614. 1 indexed citations
7.
Zhang, Zhihao, Ting Xu, Ye Gong, et al.. (2023). Exploring the role of SWI/SNF complex subunit BAF60c in lipid metabolism and inflammation in fish. iScience. 26(11). 108207–108207. 2 indexed citations
9.
Chen, Jiawei, Kun Lv, Haixia Cheng, et al.. (2023). Predicting meningioma grades and pathologic marker expression via deep learning. European Radiology. 34(5). 2997–3008. 17 indexed citations
10.
Chen, Jiawei, Lingyang Hua, Xiupeng Xu, et al.. (2023). Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma. World Neurosurgery. 176. e501–e514. 4 indexed citations
11.
Ge, Yu, Daijun Wang, Lingyang Hua, et al.. (2022). LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway. Molecules and Cells. 45(6). 388–402. 7 indexed citations
12.
Hua, Lingyang, Zhongyuan Bao, Jiaojiao Deng, et al.. (2022). Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype. Journal of Neuro-Oncology. 161(2). 193–202. 2 indexed citations
13.
Hua, Lingyang, Qian Wu, Jiaojiao Deng, et al.. (2022). Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk. Journal of Neuro-Oncology. 161(2). 267–275. 6 indexed citations
14.
He, Yu, Shuixiang Deng, Lei Xiao, et al.. (2022). Mitochondrial Quality Control: A Pathophysiological Mechanism and Therapeutic Target for Stroke. Frontiers in Molecular Neuroscience. 14. 786099–786099. 38 indexed citations
15.
Wang, Daijun, Lingyang Hua, Jiaojiao Deng, et al.. (2020). Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma. Frontiers in Oncology. 10. 568079–568079. 7 indexed citations
16.
Tang, Hailiang, Ji Xiong, Hongda Zhu, et al.. (2018). Clivus Inflammatory Pseudotumor Associated with Immunoglobulin G4-Related Disease. World Neurosurgery. 118. 71–74. 14 indexed citations
17.
Tang, Hailiang, Hongying Sha, Xing Wu, et al.. (2013). Tracking Induced Pluripotent Stem Cells–Derived Neural Stem Cells in the Central Nervous System of Rats and Monkeys. Cellular Reprogramming. 15(5). 435–442. 31 indexed citations
18.
Tang, Hailiang, Hong Chen, Ye Gong, et al.. (2013). Clinicopathological analysis of metaplastic meningioma: report of 15 cases in Huashan Hospital.. Europe PMC (PubMed Central). 22 indexed citations
20.
Gong, Ye, Jianhua Zhang, Jinfeng Gao, Jinying Lu, & Junru Wang. (2005). Slow Export of Photoassimilate from Stay‐green Leaves during Late Grain‐Filling Stage in Hybrid Winter Wheat (Triticum aestivum L.). Journal of Agronomy and Crop Science. 191(4). 292–299. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026